Muken Ross 4

What Happened Muken Ross, President of SOPHiA GENETICS SA (ticker: SOPH), sold a total of 8,129 shares in two open-market transactions on April 10 and April 13, 2026, generating roughly $38,445 in proceeds. The April 10 sale was 3,687 shares at a weighted average price of $4.69 (total ~$17,279). The April 13 sale was 4,442 shares at a weighted average price of $4.76 (total ~$21,166). These were sales (not purchases) and are typically considered routine rather than a bullish signal.

Key Details

• Transaction dates and reported weighted-average prices:
  • 2026-04-10: 3,687 shares at $4.69 (weighted avg); prices ranged $4.61–$4.77.
  • 2026-04-13: 4,442 shares at $4.76 (weighted avg); prices ranged $4.62–$4.88.
• Total shares sold: 8,129; total reported proceeds: ~$38,445.
• Purpose/footnotes: Sales were made to satisfy tax-withholding obligations from restricted stock units that vested on April 2 and April 3, 2026, and were executed under a pre-established Rule 10b5-1 trading plan (non‑discretionary).
• Weighted-average pricing: The filing notes the prices are weighted averages across multiple trades and the insider will provide a detailed breakdown on request.
• Shares owned after transaction: Not specified in the provided filing.
• Timeliness: Filing date is April 14, 2026. The April 13 trade appears reported within 1 business day; the April 10 trade appears to have been reported more than 2 business days after the transaction (may be late for that trade).

Context

• These sales were for tax withholding tied to RSU vesting and were made under a 10b5-1 plan, which reduces the significance of the trades as signals about the insider’s view of the company. Purchases generally carry more weight for investors evaluating insider conviction; routine tax-withholding sales are common and typically do not indicate a change in confidence.